This month, the Centers for Medicare & Medicaid Services announced the first wave of tools and partnerships under its Health Tech Ecosystem initiative — including the novel Medicare App Library …
Health
-
-
Wisp, a women’s telehealth company, launched a partnership with Visby Medical on Thursday to increase access to Visby’s at-home polymerase chain reaction (PCR) test for sexually transmitted infections. New York …
-
Alzheimer’s disease continues to be one of the most daunting public health challenges of our time. In the United States alone, one in nine people over age 65 is living …
-
Health
From Insight to Intervention: Why Over-the-Counter Digital Therapeutics (ODTx) are the Next Step for LLMs and Wearables
Consumers have never had more access to health information. Wearables, such as fitness trackers, smartwatches, and smart rings can track sleep, heart rate, and activity with increasing sophistication. Today’s generalist …
-
Rep. Greg Murphy (R-North Carolina) introduced the Every Dollar Counts Act on Tuesday. It would ensure out-of-pocket costs for covered prescription drugs are applied toward patients’ deductibles and maximum out-of-pocket …
-
Healthcare AI company Innovaccer announced on Wednesday that it is committing $250 million over the next three years to build out its platform of AI agents, which perform tasks across …
-
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this space is the acquisition of CrossBridge Bio, a preclinical startup …
-
Vida Health, a virtual cardiometabolic care provider, is partnering with wearable device company ŌURA to integrate ŌURA’s biometric data into Vida’s clinical programs, the companies announced on Tuesday. Vida offers …
-
AI-powered cardiac imaging company HeartFlow sued its competitor Cleerly this week, claiming the company infringed on its patents and misused proprietary technology to build a competing platform. The lawsuit, filed …
-
The journey of a Travere Therapeutics drug has culminated in a long-awaited FDA approval, making the once-daily pill the first therapy for a rare disease that, in severe cases, leads …